Glythera appoints Nigel Burns as Non-Executive Director and Ian Evetts as Commercial Director
Burns brings over 25 years experience in the Biopharmaceuticals and Biotechnology industry, having held a series of leadership roles including CEO and Founder of SweetSpot Therapeutics. Evetts joins with over 20 years experience in the Pharmaceutical industry. He has a track record of senior strategic and operational roles including Business Development and Portfolio Director at AstraZeneca.
Share
Download our apps
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.